GMMMG Consultations
GMMMG holds open consultations on decisions which affect patient care. This may include updated formulary chapters, new or updated clinical guidelines or commissioning statements, or changes to formulary status. All comments received are carefully considered by the group which made the decision, before a final recommendation is made. Decisions are then reviewed by GMMMG for information or approval, as appropriate.
Consultations typically run for six weeks, and comments are invited from all stakeholders across Greater Manchester. You can comment on current proposals via the links in the table below.
Please direct any questions to the secretariat at nuth.enquiries.gmmmg@nhs.net.
| Title | Information | Feedback | End Date |
|---|---|---|---|
|
GMMMG Clinical Reference Group proposed actions from February 2023 [link removed - consultation closed] |
On behalf of the GMMMG Clinical Reference Group, we now seek comments on the actions proposed at the February 2023 CRG meeting. This consultation period is open until 5pm on Thursday 30th March 2023. | [link removed - consultation closed] | March 30th, 2023 |
| GMMMG Clinical Reference Group proposed actions from March 2023 | On behalf of the GMMMG Clinical Reference Group, we now seek comments on the actions proposed at the March 2023 CRG meeting. This consultation period is open until midday on Tuesday 2nd May 2023. | Feedback Form | May 2nd, 2023 |
| GM IPMO Workforce Strategy | On behalf of the GM IPMO Workforce Group we now seek comments on the GM Integrating Pharmacy and Medicines Optimisation Workforce Update. This consultation period is open until 5pm on Thursday 11th May 2023. | Feedback Form | May 11th, 2023 |